Loading...
Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways
While Taxol has been reported to improve the clinical survival of breast cancer patients, subsequently developed drug-resistance of the cancer cells limits its final efficacy and applications. Previous studies suggested that Aurora A is involved in the development of the Taxol-resistance of breast c...
Saved in:
| Published in: | Oncol Rep |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
D.A. Spandidos
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652950/ https://ncbi.nlm.nih.gov/pubmed/28849180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5908 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|